30 June 2011
Acute kidney injury after procedures of orthotopic liver transplantation
Lidia Lewandowska, Joanna Matuszkiewicz-RowinskaAnn Transplant 2011; 16(2): 103-108 :: ID: 881872
Abstract
The incidence of acute kidney injury (AKI) after orthotopic liver transplantation (OLT) ranges from 40 to 70%, with 8–17% of these patients requiring renal replacement therapy. The aetiology of this syndrome is multi-factorial, and its most common cause is ischaemia in the early postoperative period, and toxicity of immunosuppressive drugs and infectious complications at long term. AKI significantly increases the risk of death and development of chronic renal failure in the late post-OLT period. We discussed in short in our work the risk factors of AKI, diagnostics and clinical management in this group of patients.
Keywords: Liver Transplantation, hepato-renal syndrome, Dialysis, calcineurin inhibitors
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






